Zhang, Wei <br/><br/>
Antiangiogenic therapy with bevacizumab in recurrent malignant gliomas: analysis of the response and core pathway aberrations.  [electronic resource] 

 -  Chinese medical journal  Jun 2009 
 - 1250-4 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2542-5641 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Angiogenesis Inhibitors--therapeutic use<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Humanized<br/>Antineoplastic Agents, Phytogenic--pharmacology<br/>Antineoplastic Combined Chemotherapy Protocols<br/>Bevacizumab<br/>Camptothecin--analogs & derivatives<br/>Disease-Free Survival<br/>Female<br/>Glioma--drug therapy<br/>Humans<br/>Immunohistochemistry<br/>Irinotecan<br/>Magnetic Resonance Imaging<br/>Male<br/>Middle Aged<br/>Young Adult